PMV Pharmaceuticals, Inc. — Form D
PMV Pharmaceuticals, Inc. of CRANBURY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-02. The offering totals $73.7M, of which $73.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-03-02
- Form: D
- Accession: 0001699382-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $73.7M
- Amount sold: $73.7M
- Investors: 9
- Date of first sale: 2017-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281658
Issuer
- Name: PMV Pharmaceuticals, Inc.
- CIK: 0001699382
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 8 CLARKE DRIVE, CRANBURY, NJ, 08512
- Phone: (609) 642-6664
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| ARNOLD LEVINE | Director | Durham, NC |
| David Mack | Director | Cranbury, NJ |
| Arnold Oronsky | Director | BOSTON, MA |
| Peter Thompson | Director | Chanhassen, MN |
| Steve Winick | Director | Cranbury, NJ |
| David Mack | Executive Officer | Cranbury, NJ |
More